Showing 81–96 of 120 results
-

40mgHPLC99.854%
$210
Retatrutide is a peptide drug acting as a triple agonist of the glucose-dependent insulinotropic polypeptide receptor (GIPR), glucagon-like peptide-1 receptor (GLP-1R), and glucagon receptor (GCGR), targeting conditions such as obesity and type 2 diabetes.
View COA (Certificate of Analysis)
-

10mgHPLC99.380%
$67
Selank, a synthetic peptide drug, is primarily used to improve anxiety, depression, and cognitive dysfunction. It exhibits anxiolytic and antidepressant effects, effectively alleviating anxiety and reducing depressive symptoms while significantly enhancing cognitive functions, including memory, attention, and learning abilities. Additionally, Selank has immunomodulatory effects, capable of enhancing the body's immune function. It is safe, well-tolerated, easy to use, and fast-acting. Selank is not only significant in the treatment of mental disorders, providing new options for conditions such as anxiety and depression, but also demonstrates potential value in neuroprotection and cognitive improvement, especially suitable for cases where conventional medications are ineffective or have side effects, helping to improve mental state and quality of life.
View COA (Certificate of Analysis)
-

10mgHPLC99.033%
$53
Semaglutide, as a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist, is widely used in the clinical treatment of type 2 diabetes. The drug exerts multiple actions by mimicking the physiological effects of endogenous GLP-1: it promotes glucose-dependent insulin secretion, inhibits glucagon release, delays gastric emptying rate, and suppresses appetite, thereby achieving the dual objectives of glycemic regulation and weight management. Given its half-life of approximately seven days, a once-weekly subcutaneous administration regimen can be adopted in clinical practice; this pharmacokinetic property significantly improves patients’ treatment adherence.
View COA (Certificate of Analysis)
-

20mgHPLC99.549%
$86
Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist that extends the half-life of natural GLP-1 through structural modification. It mimics the physiological effects of GLP-1, promoting insulin secretion in a glucose-dependent manner, inhibiting glucagon release, delaying gastric emptying, and enhancing satiety. It effectively controls blood glucose levels in patients with type 2 diabetes, significantly reduces body weight in obese or overweight individuals, and lowers the risk of cardiovascular events. It is a peptide with dual benefits of blood glucose control, weight loss, and potential cardiovascular protection.
View COA (Certificate of Analysis)
-

-

10mg
$67
Sema, a peptide nootropic and synthetic analog of adrenocorticotropic hormone (ACTH), possesses cognitive-enhancing and neuroprotective properties. Its primary effects include improving attention, memory, and learning abilities, promoting neural repair, enhancing the body’s adaptability to damaging influences such as hypoxia and cerebral ischemia, and alleviating depressive and anxiety symptoms. Additionally, Sema has demonstrated significant efficacy in treating cerebrovascular diseases, Alzheimer's disease, cerebral infarction, and other conditions. Its advantages lie in the absence of toxic side effects, non-addictiveness, and notable neuroprotective and cognitive-enhancing effects in both healthy individuals and patients, while possessing multiple biological activities such as antioxidant, anti-inflammatory, and immunomodulatory effects.
-

5mgHPLC99.429%
$119
Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), exerting its effects by stimulating the pituitary gland to secrete the body’s natural growth hormone (GH). Its primary actions include promoting muscle growth, improving body composition, enhancing metabolism, and supporting tissue repair and regeneration. Unlike direct injection of synthetic growth hormone, Sermorelin maintains a physiological pulsatile release pattern of GH through natural stimulation of pituitary secretion, thereby reducing the risk of hormonal imbalance and offering a safer, more balanced approach to hormone replacement therapy. Additionally, Semorelin exhibits notable efficacy in promoting growth and development, particularly in the treatment of growth hormone deficiency, where it aids in improving muscle mass, reducing fat accumulation, and supporting overall health.
View COA (Certificate of Analysis)
-

10mgHPLC99.842%
$57
SNAP-8, a synthetic octapeptide with unique biological activities, demonstrates significant efficacy in multiple fields. In skin care, SNAP-8 reduces facial muscle contractions by interfering with the formation of SNARE complexes and inhibiting neurotransmitter release, effectively alleviating both dynamic and static wrinkles. Additionally, the peptide regulates cellular signaling pathways to promote collagen production, enhancing skin structure and elasticity. As a natural, non-toxic, and non-invasive alternative to botulinum toxin, SNAP-8 avoids the potential side effects associated with botulinum toxin injections.
View COA (Certificate of Analysis)
-

10mgHPLC99.519%
$105
SS-31 is a mitochondria-targeting peptide drug used to treat a variety of diseases associated with mitochondrial dysfunction by protecting mitochondrial membrane function and improving energy metabolism. It binds to cardiolipin in the inner mitochondrial membrane, stabilizes mitochondrial structure and function, reduces reactive oxygen species production and enhances ATP production, thereby improving mitochondrial function. It is well tolerated and in some cases has been shown to significantly improve patients' vision, with significant supportive therapeutic effects especially in Leber's hereditary optic neuropathy (LHON). It has therapeutic effects in a variety of mitochondrial dysfunction-related diseases such as heart failure and neurodegenerative diseases, relieving symptoms and slowing disease progression.
View COA (Certificate of Analysis)
-

30mgHPLC99.508%
$265
SS-31 is a small-molecule peptide composed of four amino acids. It contains partial D-type amino acids, exhibits strong resistance to protease degradation, and is also a cell-penetrating peptide. As a phospholipase A2 inhibitor and mitochondrial-targeted peptide, SS-31 specifically accumulates on the inner mitochondrial membrane and exerts its effects through multiple mechanisms.
View COA (Certificate of Analysis)
-

50mgHPLC99.576%
$468
SS-31, also known as Elamipretide, possesses lipophilic characteristics enabling it to penetrate cell membranes and specifically localize to the inner mitochondrial membrane, demonstrating targeted action. As a mitochondrial-targeted peptide, SS-31 is molecularly engineered to interact with phospholipid components of the inner mitochondrial membrane, enabling precise regulation of mitochondrial structure and function. It is classified as a mitochondrial function modulator.
View COA (Certificate of Analysis)
-

10mgHPLC99.487%
$240
Survodutide is a new-generation dual agonist of the glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR), jointly developed by Boehringer Ingelheim and Zealand Pharma in Denmark.
View COA (Certificate of Analysis)
-

10mgHPLC99.773%
$153
TB500, namely the synthetic analog of Thymosin Beta-4 (Tβ4), is a polypeptide with broad biological activities. By regulating the dynamic equilibrium of actin, it promotes cell migration, proliferation, and differentiation, thus playing a crucial role in tissue repair and regeneration.
View COA (Certificate of Analysis)
-

20mgHPLC99.203%
$277
TB500, namely the synthetic analog of Thymosin Beta-4 (Tβ4), is a polypeptide with broad biological activities. By regulating the dynamic equilibrium of actin, it promotes cell migration, proliferation, and differentiation, thus playing a crucial role in tissue repair and regeneration.
View COA (Certificate of Analysis)
-

-

750mcgHPLC99.899%
$100
Teriparatide is a recombinant human parathyroid hormone (PTH) analog composed of the first 34 amino acids of human parathyroid hormone. It regulates bone metabolism by mimicking the physiological actions of endogenous parathyroid hormone. Teriparatide is the first synthetic anabolic drug approved for severe osteoporosis. Its structure exhibits high homology with endogenous PTH, enabling activation of the PTH receptor to modulate osteoclast metabolic activity.
View COA (Certificate of Analysis)